Inflammatory biomarkers include cellular factors (for example, lymphocytes) or molecular factors (for example, cytokines) either present in the circulation or localized to tissues. Therefore, efforts have been made to find markers that indicate the presence of preclinical or clinical disease. Inflammation mediates all stages of the disease, from initiation to the thrombotic complications of atherosclerosis.